Miho Maeda

Title: Miho Maeda: Innovator in Spinal Cord Injury Treatment

Introduction

Miho Maeda is a prominent inventor based in Suita, Japan. She has made significant contributions to the field of medical treatments, particularly focusing on spinal cord injuries. Her innovative approach has led to the development of a unique formulation aimed at improving patient outcomes.

Latest Patents

Miho Maeda holds a patent for a preparation designed for the treatment of spinal cord injury. This invention is a solid sustained-release formulation that includes an agent for inhibiting semaphorin 3A as its active ingredient. The formulation comprises a pharmaceutically acceptable, hardly water-soluble solid substance, with silicone serving as the carrier. This innovative approach has the potential to enhance therapeutic efficacy in spinal cord injury treatments.

Career Highlights

Throughout her career, Miho Maeda has worked with notable organizations, including Sumitomo Dainippon Pharma Co., Ltd. and Keio University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Miho has collaborated with esteemed colleagues such as Akiyoshi Kishino and Akihiko Sano. These partnerships have further enriched her research and development efforts, leading to advancements in medical treatments.

Conclusion

Miho Maeda's work in developing innovative treatments for spinal cord injuries showcases her dedication to improving healthcare. Her patent and collaborations reflect her commitment to advancing medical science and enhancing patient care.